STOCK TITAN

Amer Shared Hosp Stock Price, News & Analysis

AMS NYSE

Welcome to our dedicated page for Amer Shared Hosp news (Ticker: AMS), a resource for investors and traders seeking the latest updates and insights on Amer Shared Hosp stock.

American Shared Hospital Services (AMS: NYSE) delivers innovative financing solutions for advanced cancer treatment technologies, including Gamma Knife radiosurgery and proton beam therapy systems. This page provides investors and healthcare professionals with timely updates on AMS's strategic partnerships, financial performance, and technology deployments.

Access curated press releases and news articles covering AMS's domestic operations and international joint ventures in Latin America. Track developments in radiation therapy financing, equipment upgrades, and oncology service expansions. Our repository ensures stakeholders stay informed about AMS's role in making cutting-edge cancer treatment accessible worldwide.

Explore updates on key areas: quarterly earnings reports, collaborations with medical institutions, regulatory milestones, and new technology implementations like Elekta's Esprit systems. Bookmark this page for direct access to verified information supporting informed decisions about AMS's market position and healthcare impact.

Rhea-AI Summary

American Shared Hospital Services (AMS) reported a strong financial performance for Q4 2022, with revenue exceeding $5 million for the second time in the year, marking a 7.4% increase from Q4 2021. Net income rose by 12% to $246,000 or $0.04 per share. Full-year revenue reached nearly $20 million, representing a 12% increase, while net income surged six-fold to $1.3 million or $0.21 per share. Major highlights include a 33.4% increase in proton therapy revenue, a solid cash position of $12.5 million, and a first order of 2023 valued at $1.3 million. The company is also advancing its joint ventures in Mexico and Ecuador.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.77%
Tags
-
Rhea-AI Summary

American Shared Hospital Services (AMS) announced a quarterly conference call scheduled for March 24, 2023, at 1:00 PM ET to discuss its fourth quarter and year-end 2022 financial results. The financial results press release will be available before market opening on the same date. Investors can participate in the call by dialing 1 (844) 413-3972 and joining the AMS call. A simultaneous webcast will be accessible on the AMS website. A call replay will be available through March 31, 2023, at 1 (877) 344-7529 with access code 7388246. AMS provides technology solutions for radiation therapy and is a leader in Gamma Knife radiosurgery.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.05%
Tags
-
Rhea-AI Summary

American Shared Hospital Services (NYSE American: AMS) announced key management changes effective March 7, 2023. Ray Stachowiak transitions to Executive Chairman after serving as CEO since October 2020. Peter Gaccione, previously COO, is named CEO, bringing over 40 years in medical oncology. AMS has booked its first order of 2023, valued at $1.3 million, which is expected to ship in the second quarter. The company is also searching for a new CFO as Craig Tagawa remains President and CFO until a successor is found. Stachowiak expressed confidence in the new management team's capability to drive AMS forward.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.33%
Tags
none
Rhea-AI Summary

American Shared Hospital Services (AMS) reported a strong third quarter for 2022, with total revenue increasing by 17.8% to $4.83 million. Notably, proton therapy revenue surged by 82% due to higher volumes and average reimbursements. The gross margin expanded to 40.5%, resulting in gross profit of $2 million, a 33.4% increase. Net income rose to $316,000 or $0.05 per share. Adjusted EBITDA also grew by 28% to $1.99 million. As of September 30, 2022, AMS had cash reserves of $11.66 million, indicating robust financial health.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.23%
Tags
none
-
Rhea-AI Summary

American Shared Hospital Services (NYSE: AMS) will host a quarterly conference call on November 10, 2022, at 3:00 pm ET to discuss its third-quarter financial results. The press release detailing these results will be available before market open on the same day. The call can be accessed by dialing 1 (844) 413-3972 or via a webcast on the company's website. A replay will be available until November 17, 2022. AMS specializes in providing technology solutions for stereotactic radiosurgery and advanced radiation therapy equipment.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.38%
Tags
-
Rhea-AI Summary

American Shared Hospital Services (AMS) will present at the 15th Annual Main Event on October 25, 2022, at 8:00 AM PT in Los Angeles. The event will showcase over 200 companies, providing a platform for corporate overviews and investor meetings. AMS specializes in advanced radiation therapy solutions, including stereotactic radiosurgery and Gamma Knife equipment for treating brain tumors. The presentation will be led by CEO Ray Stachowiak and President/CFO Craig Tagawa. Investors can register to watch the presentation live online.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.89%
Tags
conferences
Rhea-AI Summary

American Shared Hospital Services (AMS) has appointed Peter Gaccione as Chief Operating Officer, effective September 7, 2022. Gaccione brings over 40 years of experience in Radiation Oncology, having previously led Myocardial Solutions Inc. and held executive roles at Elekta AB. His leadership is expected to strengthen AMS's management team and enhance growth opportunities in photon and proton technologies. CEO Ray Stachowiak expressed confidence in Gaccione's market knowledge and relationship-building skills, reinforcing AMS's commitment to providing comprehensive cancer treatment solutions.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.9%
Tags
management
-
Rhea-AI Summary

American Shared Hospital Services (AMS) reported strong second-quarter results for 2022, achieving total revenue of $5,034,000, up 12.5% compared to the same period in 2021, marking the highest revenue since Q3 2019. Proton therapy revenue soared by 49%, while Gamma Knife revenue fell by 6.9%. Net income reached $497,000 or $0.08 per share, a notable increase from a net loss of $87,000 in Q2 2021. AMS's cash reserves also expanded to $11,967,000, providing the company with substantial resources for growth initiatives.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
12.4%
Tags
none
-
Rhea-AI Summary

American Shared Hospital Services (NYSE American: AMS) will hold a quarterly conference call on August 12, 2022, to discuss its second quarter 2022 financial results. The results will be released after market close on August 11, 2022. Interested participants can join the call by dialing 1 (844) 413-3972 and accessing the webcast through the Company’s website at www.ashs.com. A replay will be available until August 19, 2022.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.35%
Tags
Rhea-AI Summary

American Shared Hospital Services (AMS) reported a total revenue increase of 11.1% to $4,847,000 in Q1 2022, driven by a 33.2% increase in proton therapy revenue. Operating income surged to $600,000, a 567% increase, while net income reached $269,000 or $0.04 per share. Adjusted EBITDA grew by 20.1% to $1,922,000. AMS also announced a joint venture in Puebla, Mexico for a new radiation therapy facility. Cash reserves stood at $8.4 million with shareholders' equity at $24.72 million as of March 31, 2022.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4%
Tags

FAQ

What is the current stock price of Amer Shared Hosp (AMS)?

The current stock price of Amer Shared Hosp (AMS) is $2.4 as of June 25, 2025.

What is the market cap of Amer Shared Hosp (AMS)?

The market cap of Amer Shared Hosp (AMS) is approximately 15.9M.
Amer Shared Hosp

NYSE:AMS

AMS Rankings

AMS Stock Data

15.87M
3.24M
48.6%
16.56%
0.39%
Medical Care Facilities
Services-medical Laboratories
Link
United States
SAN FRANCISCO